Two new polypharmacy and deprescribing bulletins are available.
View > >
Antibacterials
Antibiotic resistance and the lack of new antibiotics being developed to replace ones for which resistance is a significant issue are still ongoing concerns. It is imperative that we do all that we can to preserve the usefulness of the antibiotics we currently have.
This bulletin discusses the review of treatment with anticholinergic drugs and the different scales available to support review. Support materials are available to identify the risk in patients and support appropriate action to reduce anticholinergic burden.
View > >
Our Anticholinergic burden e-learning course is CPD certified. This course is for medicines management teams, GPs, practice nurses, practice pharmacists and non-medical prescribers.
View > >
The constipation bulletin reviews the treatments available for constipation (including newer therapies) and provides advice and guidance on when they should be used and for how long.
View > >
The dependence forming medicines (DFMs) resources provide an overview of DFMs and signpost to PrescQIPP resources which support medicines optimisation projects in this area.
View > >
This resource supports the review of the prescribing of immediate-release fentanyl in line with national guidance. Deprescribing and switching options are considered.
View > >
This bulletin offers advice on managing new patients with insomnia, recommends cost-effective prescribing choices, and encourages you to review chronic hypnotic users with a view to helping them withdraw from treatment.
View > >
This resource is an update to the IMPACT bulletin. It identifies clinical and deprescribing priority with recommendations and considerations for appropriately continuing or stopping medicines.
View > >
These resources support the implementation of local campaigns for the World Health Organisation (WHO) global patient safety challenge, medication without harm.
View > >
These resources look at the safety implications of long term treatment with NSAIDs and support treatment initiation and review.
View > >
The opioid patches bulletin focuses on the safe and appropriate prescribing of opioid patches as well as cost effective treatment choices. An audit is available to help support the review of patients already prescribed opioid patches to assess whether there is a continued need for treatment with patches.
View > >
The bulletin and resources provide further information on the evidence base for for using oxycodone/naloxone prolonged release tablets, the rationale to stop treatment and also suggests alternative treatment options.
View > >
This bulletin and implementation resources focus on reducing PPI prescribing for safety reasons by reviewing the continued need and stepping down or deprescribing where appropriate in line with current guidance.
View > >
The PrescQIPP reducing antipsychotic prescribing in dementia toolkit is a resource aimed at healthcare professionals and carers, which can be used to support these symptoms without the use of antipsychotics.
View > >
In this webinar, Cherise Howson and Sajida Khatri showcase the resources in the reducing antipsychotics in dementia toolkit and discussed the evidence behind the recommendations.
View > >
This bulletin focuses on Tramacet® (paracetamol 325mg/tramadol 37.5mg) and provides the rationale for new patients to be initiated on paracetamol or paracetamol with codeine. Current patients should be considered for a switch to paracetamol alone or paracetamol with codeine.
View > >
